Cabaletta Bio, Inc. — Director's Dealing 2025

Jun 10, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cabaletta Bio, Inc. (CABA)
CIK: 0001759138
Period of Report: 2025-06-09

Reporting Person: HENRIQUES RICHARD C JR (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-06-09	Stock Option (Right to Buy)	$2.37	A	22000	Acquired	2035-06-08	Common Stock (22000)	Direct

Footnotes

F1: This option shall vest in full upon the earlier of (i) June 9, 2026 or (ii) the date of the next annual meeting of the Corporation's stockholders.